Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.23.1
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accounts payable:    
Clinical and regulatory expenses $ 361 $ 534
Professional fees 626 477
Selling expenses 1,363 932
Manufacturing costs 650 378
Non-employee board member compensation 484 136
Other vendors 301 262
Total accounts payable 3,785 2,719
Accrued interest payable, related parties 144 91
Accrued interest payable 2,381 579
Accrued expenses:    
Payroll expenses 1,263 1,097
Government rebates and other rebates 5,536 4,371
Other accrued expenses 440 332
Total accrued expenses 7,239 5,800
Total accounts payable and accrued expenses $ 13,549 $ 9,189